AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein

Blood

Volumn 117, Issue 16, 2011, Pages 4328-4337

  Steffen, Björn ^a,b   Knop, Markus ^a   Bergholz, Ulla ^c   Vakhrusheva, Olesya ^b   Rode, Miriam ^a   Köhler, Gabriele ^d   Henrichs, Marcel Philipp ^a   Bulk, Etmar ^a   Hehn, Sina ^b   Stehling, Martin ^e   Dugas, Martin ^a   Bäumer, Nicole ^a   Tschanter, Petra ^a   Brandts, Christian ^b   Koschmieder, Steffen ^a   Berdel, Wolfgang E ^a   Serve, Hubert ^a,b   Stocking, Carol ^c   Müller Tidow, Carsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL ENHANCER OF SPLIT PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL RENEWAL; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HELA CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SPLEEN;

EID: 79955947577     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-242545     Document Type: Article

References (24)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. (Pubitemid 30046295)
2. Basecke J, Schwieger M, Griesinger F, et al. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation. Leuk Lymphoma. 2005;46(2):265-272. (Pubitemid 40185958)
3. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 2002;1(1):63-74. (Pubitemid 41039177)
4. Mulloy JC, Cammenga J, Berguido FJ, et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood. 2003;102(13):4369-4376. (Pubitemid 37494097)
5. Rhoades KL, Hetherington CJ, Harakawa N, et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood. 2000;96(6):2108-2115.
6. Schwieger M, Lohler J, Friel J, Scheller M, Horak I, Stocking C. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J Exp Med. 2002;196(9):1227-1240. (Pubitemid 35304188)
7. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434(7035):843-850. (Pubitemid 40558990)
8. Müller-Tidow C, Steffen B, Cauvet T, et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol. 2004;24(7):2890-2904. (Pubitemid 38381278)
9. Dayyani F, Wang J, Yeh JR, et al. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood. 2008;111(8):4338-4347.
10. Fraga MF, Berdasco M, Ballestar E, et al. Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies. Cancer Res. 2008;68(11):4116-4122.
11. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387-398. (Pubitemid 351589714)
12. Tickenbrock L, Hehn S, Sargin B, et al. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4. Int J Oncol. 2008;33(6):1215-1221.
13. Tickenbrock L, Hehn S, Sargin B, et al. Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia. Int J Hematol. 2008;88(2):174-180.
14. Tickenbrock L, Schwäble J, Wiedehage M, et al. Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction. Blood. 2005;105(9):3699-3706. (Pubitemid 40628219)
15. Petropoulos K, Arseni N, Schessl C, et al. A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis. J Exp Med. 2008;205(3):515-522. (Pubitemid 351439299)
16. Gasperowicz M, Otto F. Mammalian Groucho homologs: redundancy or specificity? J Cell Biochem. 2005;95(4):670-687. (Pubitemid 41420155)
17. Wang WF, Wang YG, Reginato AM, Plotkina S, Gridley T, Olsen BR. Growth defect in Grg5 null mice is associated with reduced Ihh signaling in growth plates. Dev Dyn. 2002;224(1):79-89. (Pubitemid 34464935)
18. Worch J, Tickenbrock L, Schwäble J, et al. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells. Oncogene. 2004;23(57):9162-9172. (Pubitemid 40069686)
19. Beyer WR, Westphal M, Ostertag W, von Laer D. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol. 2002;76(3):1488-1495. (Pubitemid 34066448)
20. Yan M, Kanbe E, Peterson LF, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med. 2006;12(8):945-949. (Pubitemid 44175147)
21. Valk PJ, Delwel R, Lowenberg B. Gene expression profiling in acute myeloid leukemia. Curr Opin Hematol. 2005;12(1):76-81. (Pubitemid 40189242)
22. Sekkai D, Gruel G, Herry M, et al. Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells. 2005;23(10):1634-1642. (Pubitemid 41741013)
23. Büchner T, Berdel WE, Haferlach C, et al. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol. 2009;27(1):61-69.
24. Preudhomme C, Sagot C, Boissel N, et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Blood. 2002;100(8):2717-2723.